Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1)

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1)

PREFACE  

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):1

The importance of dosimetry in nuclear medicine therapy practice

Bisi G.

PDF

FOREWORD  DOSIMETRY IN NUCLEAR MEDICINE - PART I

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):2-4

Dosimetry in nuclear medicine therapy

Chiesa C., Lassmann M.

PDF

FOREWORD  DOSIMETRY IN NUCLEAR MEDICINE - PART I

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):5-20

Dosimetry in nuclear medicine therapy: what are the specifics in image quantification for dosimetry?

Bardiès M., Buvat I.

PDF

FOREWORD  DOSIMETRY IN NUCLEAR MEDICINE - PART I

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):21-43

Quantitative imaging of 124I with PET/ CT in pretherapy lesion dosimetry Effects impairing image quantification and their corrections

Jentzen W., Freudenberg L., Bockisch A.

Abstract PDF

FOREWORD  DOSIMETRY IN NUCLEAR MEDICINE - PART I

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):44-56

From imaging to dosimetry and biological effects

Konijnenberg M.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):57-65

Could [18]F-fluorodeoxyglucose PET/CT change the therapeutic management of stage IV thyroid cancer with positive 131I whole body scan?

Piccardo A., Foppiani L., Morbelli S., Bianchi P., Barbera F., Biscaldi E., Altrinetti V., Villavecchia G., Cabria M.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):66-71

Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of 67Ga imaging and 18F-FDG PET

Keijsers R. G., Grutters J. C., Thomeer M., Du Bois R. M., Van Buul M. M., Lavalaye J., Van Den Bosch J. M., Verzijlbergen F. J.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):72-80

Prognostic role of the PET parameter maximum standardized uptake value in non small cell lung cancer: analysis in tumour of diameter ≥; and <25 mm

Pelosi E., Billè A., Skanjeti A., Errico L., Arena V., Ardissone F., Borasio P., Mancini M.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):81-90

[18F]FDG-PET/CT monitoring early identifies advan-ced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy

Martoni A. A., Fanti S., Zamagni C., Rosati M., De Iaco P., D’Errico Grigioni A., Castellucci P., Quercia S., Musto A., Ricci Maccarini L., Lopci E., Bernardi A.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):91-102

Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after 186Re-HEDP therapy

Zafeirakis A., Zissimopoulos A., Baziotis N., Limouris G. S.

Abstract PDF

LETTERS TO THE EDITOR  

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):103-4

Technetium-99m supply shortage. Possible solutions in every day nuclear cardiology practice

Marcassa C., Campini R., Zoccarato O., Calza P.

PDF

top of page